303 related articles for article (PubMed ID: 24854643)
1. Cell therapy for kidney injury: different options and mechanisms--kidney progenitor cells.
Osafune K
Nephron Exp Nephrol; 2014; 126(2):64. PubMed ID: 24854643
[TBL] [Abstract][Full Text] [Related]
2. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
[TBL] [Abstract][Full Text] [Related]
3. Kidney regeneration from human induced pluripotent stem cells.
Mae S; Osafune K
Curr Opin Organ Transplant; 2015 Apr; 20(2):171-7. PubMed ID: 25856179
[TBL] [Abstract][Full Text] [Related]
4. Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers.
Hoshina A; Kawamoto T; Sueta SI; Mae SI; Araoka T; Tanaka H; Sato Y; Yamagishi Y; Osafune K
Sci Rep; 2018 Apr; 8(1):6375. PubMed ID: 29686294
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent Stem Cells to Rebuild a Kidney: The Lymph Node as a Possible Developmental Niche.
Francipane MG; Lagasse E
Cell Transplant; 2016; 25(6):1007-23. PubMed ID: 26160801
[TBL] [Abstract][Full Text] [Related]
6. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.
Imberti B; Tomasoni S; Ciampi O; Pezzotta A; Derosas M; Xinaris C; Rizzo P; Papadimou E; Novelli R; Benigni A; Remuzzi G; Morigi M
Sci Rep; 2015 Mar; 5():8826. PubMed ID: 25744951
[TBL] [Abstract][Full Text] [Related]
7. Using stem and progenitor cells to recapitulate kidney development and restore renal function.
Murray PA; Woolf AS
Curr Opin Organ Transplant; 2014 Apr; 19(2):140-4. PubMed ID: 24480967
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction.
Shen WC; Chou YH; Huang HP; Sheen JF; Hung SC; Chen HF
Stem Cell Res Ther; 2018 Dec; 9(1):344. PubMed ID: 30526689
[TBL] [Abstract][Full Text] [Related]
10. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
11. Engineering kidney cells: reprogramming and directed differentiation to renal tissues.
Kaminski MM; Tosic J; Pichler R; Arnold SJ; Lienkamp SS
Cell Tissue Res; 2017 Jul; 369(1):185-197. PubMed ID: 28560692
[TBL] [Abstract][Full Text] [Related]
12. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
13. Regenerating the kidney using human pluripotent stem cells and renal progenitors.
Becherucci F; Mazzinghi B; Allinovi M; Angelotti ML; Romagnani P
Expert Opin Biol Ther; 2018 Jul; 18(7):795-806. PubMed ID: 29939787
[TBL] [Abstract][Full Text] [Related]
14. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
15. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
16. Generation of Urine-Derived Induced Pluripotent Stem Cell Line from Patients with Acute Kidney Injury.
Jin Y; Zhang M; Li M; Zhang H; Zhang F; Zhang H; Yin Z; Zhou M; Wan X; Li R; Cao C
Cell Reprogram; 2021 Oct; 23(5):290-303. PubMed ID: 34648385
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats.
Lee PY; Chien Y; Chiou GY; Lin CH; Chiou CH; Tarng DC
Cell Transplant; 2012; 21(12):2569-85. PubMed ID: 22507855
[TBL] [Abstract][Full Text] [Related]
18. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
Lichner Z; Mac-Way F; Yousef GM
Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
[TBL] [Abstract][Full Text] [Related]
20. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
Imamura M; Hikabe O; Lin ZY; Okano H
Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
